Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 6 (June)

1. Is there a relationship between childhood Helicobacter pylori infection and iron deficiency anemia?
   J Trop Pediatr, 51(3): 166-9. [Abstract] [Full-text]
2. Molecular analysis of Iranian families with sickle cell disease.
   J Trop Pediatr, 51(3): 136-40. [Abstract] [Full-text]
3. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia.
   J Clin Invest, 115(6): 1562-70. [Abstract] [Full-text]
4. Understanding globin regulation in beta-thalassemia: it's as simple as alpha, beta, gamma, delta.
   J Clin Invest, 115(6): 1470-3. [Abstract] [Full-text]
5. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
   Am J Gastroenterol, 100(6): 1415-9. [Abstract] [Full-text]
6. Contemporary treatments for twin-twin transfusion syndrome.
   Obstet Gynecol, 105(6): 1469-77. [Abstract] [Full-text]
7. The prevalence of iron deficiency among patients presenting with colorectal cancer.
   Colorectal Dis, 7(4): 398-402. [Abstract] [Full-text]
8. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.
   Blood, 105(12): 4620-6. [Abstract] [Full-text]
9. Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia.
   Blood, 105(12): 4627-34. [Abstract] [Full-text]
10. Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells.
    Am J Hematol, 79(2): 89-96. [Abstract] [Full-text]
11. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.
    Am J Hematol, 79(2): 107-13. [Abstract] [Full-text]
12. Human parvovirus B19 in patients with aplastic anemia.
    Am J Hematol, 79(2): 166-7. [Abstract] [Full-text]
13. Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion.
    Pediatr Blood Cancer, 45(1): 43-7. [Abstract] [Full-text]
14. Outcome of holistic care in Nigerian patients with sickle cell anaemia.
    Clin Lab Haematol, 27(3): 195-9. [Abstract] [Full-text]
15. Evaluation of serum transferrin receptor assay in a centralized iron screening service.
    Clin Lab Haematol, 27(3): 190-4. [Abstract] [Full-text]
16. Hydroxyurea in thalassemia intermedia--a promising therapy.
    Ann Hematol, 84(7): 441-6. [Abstract] [Full-text]
17. Deferiprone as an oral iron chelator in sickle cell disease.
    Ann Hematol, 84(7): 434-40. [Abstract] [Full-text]
18. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases.
    J Infect Dis, 192(1): 178-86. [Abstract] [Full-text]
19. Prevalence of iron deficiency with and without anemia in recreationally active men and women.
    J Am Diet Assoc, 105(6): 975-8. [Abstract] [Full-text]
20. Associations between frequencies of a susceptible TNF-alpha promoter allele and protective alpha-thalassaemias and malaria parasite incidence in Vanuatu.
    Trop Med Int Health, 10(6): 544-9. [Abstract] [Full-text]
21. Growth hormone secretion in adult patients with thalassaemia.
    Clin Endocrinol (Oxf), 62(6): 667-71. [Abstract] [Full-text]
22. Increasing incidence of post-kidney transplant anemia in children.
    Am J Transplant, 5(7): 1713-8. [Abstract] [Full-text]
23. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.
    Transfus Apher Sci, 32(3): 315-21. [Abstract] [Full-text]
24. Two beta-globin cluster-linked polymorphic loci in thalassemia patients of variable levels of fetal hemoglobin.
    Eur J Haematol, 75(1): 47-53. [Abstract] [Full-text]
25. Preoperative transfusion in sickle cell disease: a survey of practice in England.
    Eur J Haematol, 75(1): 14-21. [Abstract] [Full-text]
26. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
    Arch Orthop Trauma Surg, 125(5): 342-7. [Abstract] [Full-text]
27. Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul study).
    Am J Cardiol, 95(12): 1474-7. [Abstract] [Full-text]
28. Vascular distribution patterns in monochorionic twin placentas.
    Placenta, 26(6): 471-5. [Abstract] [Full-text]
29. Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation.
    Biochim Biophys Acta, 1740(3): 467-71. [Abstract] [Full-text]
30. Factors associated with severe anaemia in Zambian children admitted with Plasmodium falciparum malarial anaemia.
    Ann Trop Paediatr, 25(2): 87-90. [Abstract] [Full-text]
31. Antenatal thalassaemia carrier testing: women's perceptions of "information" and "consent".
    J Med Screen, 12(2): 69-77. [Abstract] [Full-text]
32. Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassaemia major.
    J Paediatr Child Health, 41(5): 265-8. [Abstract] [Full-text]
33. Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene.
    Br J Haematol, 129(6): 839-46. [Abstract] [Full-text]
34. Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.
    Br J Haematol, 129(6): 771-5. [Abstract] [Full-text]
35. Psychological complications in sickle cell disease.
    Br J Haematol, 129(6): 723-9. [Abstract] [Full-text]
36. Identification, molecular characterization, and experimental transmission of a new hemoplasma isolate from a cat with hemolytic anemia in Switzerland.
    J Clin Microbiol, 43(6): 2581-5. [Abstract] [Full-text]
37. Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin.
    Kidney Int, 68(1): 246-55. [Abstract] [Full-text]
38. Secondary causes of restless legs syndrome in older people.
    Age Ageing, 34(4): 349-52. [Abstract] [Full-text]
39. Prosthetic heart valves' mechanical loading of red blood cells in patients with hereditary membrane defects.
    J Biomech, 38(8): 1557-65. [Abstract] [Full-text]
40. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin.
    Nephrology (Carlton), 10(3): 317-20. [Abstract] [Full-text]
41. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients.
    Nephrology (Carlton), 10(3): 264-9. [Abstract] [Full-text]
42. Birth of a healthy infant following trophectoderm biopsy from blastocysts for PGD of beta-thalassaemia major.
    Hum Reprod, 20(7): 1855-9. [Abstract] [Full-text]
43. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients.
    Dis Colon Rectum, 48(6): 1153-60. [Abstract] [Full-text]
44. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Br J Ophthalmol, 89(7): 815-9. [Abstract] [Full-text]
45. Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis.
    Transplant Proc, 37(5): 2148-50. [Abstract] [Full-text]
46. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Exp Hematol, 33(7): 819-27. [Abstract] [Full-text]
47. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
    Exp Hematol, 33(7): 804-10. [Abstract] [Full-text]
48. Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalence.
    Trans R Soc Trop Med Hyg, 99(8): 561-7. [Abstract] [Full-text]
49. A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia.
    Ann Oncol, 16(7): 1192-8. [Abstract] [Full-text]
50. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid.
    Rheumatol Int, 25(5): 388-90. [Abstract] [Full-text]
51. The effects of iron deficiency on estradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related anemia.
    Blood, 106(1): 67-74. [Abstract] [Full-text]
52. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.
    Blood, 106(1): 372-5. [Abstract] [Full-text]
53. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia.
    Blood, 106(1): 362-7. [Abstract] [Full-text]
54. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells.
    Blood, 106(1): 75-85. [Abstract] [Full-text]
55. Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya.
    Blood, 106(1): 368-71. [Abstract] [Full-text]
56. Pre-treatment erythropoietin levels cannot be used to predict individual response to epoetin alfa in anaemic cancer patients.
    Curr Med Res Opin, 21: S19-21. [Abstract] [Full-text]
57. Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients.
    Curr Med Res Opin, 21: S16-8. [Abstract] [Full-text]
58. Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
    Curr Med Res Opin, 21: S12-5. [Abstract] [Full-text]
59. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.
    Curr Med Res Opin, 21: S9-11. [Abstract] [Full-text]
60. Benefits of epoetin alfa for cancer patients' quality of life are confirmed after modelling to account for missing data.
    Curr Med Res Opin, 21: S6-8. [Abstract] [Full-text]
61. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
    Curr Med Res Opin, 21: S3-5. [Abstract] [Full-text]
62. Epoetin alfa (Eprex) and quality of life.
    Curr Med Res Opin, 21: S1-2. [Abstract] [Full-text]
63. Mini-laparoscopic cholecystectomy in children under 10 years of age with sickle cell disease.
    ANZ J Surg, 75(7): 562-5. [Abstract] [Full-text]
64. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood.
    Hepatology, 42(1): 35-43. [Abstract] [Full-text]
65. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis.
    Clin Exp Nephrol, 9(2): 158-63. [Abstract] [Full-text]
66. Association of deranged adrenal steroid metabolism with anemia in chronic heart failure.
    Am J Cardiol, 96(1): 101-3. [Abstract] [Full-text]
67. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.
    J Thromb Haemost, 3(7): 1432-6. [Abstract] [Full-text]
68. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease.
    Acta Haematol, 113(4): 228-33. [Abstract] [Full-text]
69. Coincidental deficiency of the posterior arch of the atlas and thalassaemia minor: possible pitfalls in a trauma victim.
    Emerg Med J, 22(7): 526-8. [Abstract] [Full-text]
70. The measurement of urinary hydroxyurea in sickle cell anaemia.
    Br J Haematol, 130(1): 138-44. [Abstract] [Full-text]
71. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice.
    Br J Haematol, 130(1): 130-7. [Abstract] [Full-text]
72. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia.
    Br J Haematol, 130(1): 99-106. [Abstract] [Full-text]
73. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Br J Haematol, 130(1): 11-25. [Abstract] [Full-text]
74. Chronic blood transfusion therapy practices to treat strokes in children with sickle cell disease.
    J Am Acad Nurse Pract, 17(7): 277-82. [Abstract] [Full-text]
75. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
    Transpl Infect Dis, 7(1): 30-3. [Abstract] [Full-text]
76. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.
    Pediatr Blood Cancer, 45(2): 212-6. [Abstract] [Full-text]
77. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients.
    Pediatr Blood Cancer, 45(2): 184-90. [Abstract] [Full-text]
78. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia.
    Pediatr Blood Cancer, 45(2): 170-5. [Abstract] [Full-text]
79. Bone marrow and blood plasma levels of IL-8 in aplastic anemia and their relationship with disease severity.
    Am J Hematol, 79(3): 240-2. [Abstract] [Full-text]
80. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
    Am J Hematol, 79(3): 198-201. [Abstract] [Full-text]
81. Fibrocongestive splenomegaly in sickle cell disease: a distinct clinicopathological entity in the Eastern province of Saudi Arabia.
    Am J Hematol, 79(3): 180-6. [Abstract] [Full-text]

© 2004-2010 Anemia Research Today. All Rights Reserved.